Drugs / Ribocyclib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04753177 | Jan 2021 → Jan 2023 | — | Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ribocyclib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04753177 ↗ |